Literature DB >> 31292851

Total and ionized calcium and magnesium are significantly lowered in drug-naïve depressed patients: effects of antidepressants and associations with immune activation.

Arafat Hussein Al-Dujaili1, Hussein Kadhem Al-Hakeim2, Ahmed Jasim Twayej3, Michael Maes4,5,6,7.   

Abstract

Major depressive disorder (MDD) is associated with alterations in calcium (Ca) and magnesium (Mg), as well as circulating pro- and anti-inflammatory cytokines. Anti-inflammatory drugs are commonly used as adjuvant treatments for MDD. However, no studies examined the effects of a combinatorial treatment with sertraline and ketoprofen, an anti-inflammatory drug, on Ca and Mg levels in MDD. The present study examined a) differences in both cations between drug-naïve MDD patients and controls, and b) the effects of sertraline and ketoprofen on Ca and Mg (both total and ionized). In the same patients, we also examined the associations between both cations and IL-1β, IL-4, IL-6, IL-18, IFN-γ, TGF-β1, zinc, and indoleamine 2,3-dioxygenase (IDO). Clinical improvement was assessed using the Beck Depression Inventory-II (BDI-II) at baseline and after follow up for 2 months. Serum Ca and Mg (total and ionized) were significantly lower in MDD patients as compared with controls, while treatment significantly increased calcium but decreased magnesium levels. There were significant and inverse correlations between the BDI-II scores from baseline to endpoint and Ca (both total and ionized), but not Mg, levels. The effects of calcium on the BDI-II score remained significant after considering the effects of zinc, IDO and an immune activation z unit-weighted composite score based on the sum of all cytokines. There was a significant and inverse association between this immune activation index and calcium levels from baseline to endpoint. In conclusion, lowered levels of both cations play a role in the pathophysiology of major depression. Antidepressant-induced increases in Ca are associated with clinical efficacy and attenuation of the immune response. The suppressant effect of antidepressants on Mg levels is probably a side effect of those drugs. New antidepressant treatments should be developed that increase the levels both Ca and Mg. Graphical abstract.

Entities:  

Keywords:  Cytokines; Depression; Indoleamine 2,3-dioxygenase; Inflammation; Neuro-immune

Mesh:

Substances:

Year:  2019        PMID: 31292851     DOI: 10.1007/s11011-019-00458-5

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  72 in total

1.  Recurrent psychotic depression associated with hypercalcemia and parathyroid adenoma.

Authors:  M M MANDEL
Journal:  Am J Psychiatry       Date:  1960-09       Impact factor: 18.112

2.  Lower serum zinc in major depression in relation to changes in serum acute phase proteins.

Authors:  M Maes; N De Vos; P Demedts; A Wauters; H Neels
Journal:  J Affect Disord       Date:  1999-12       Impact factor: 4.839

3.  Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs.

Authors:  B Cryer; M Feldman
Journal:  Am J Med       Date:  1998-05       Impact factor: 4.965

4.  Serum calcium measurement: Total versus free (ionized) calcium.

Authors:  Laxmayya Sava; Sandhya Pillai; Umesh More; Alka Sontakke
Journal:  Indian J Clin Biochem       Date:  2005-07

5.  IL-10 is associated with increased mu-opioid receptor levels in major depressive disorder.

Authors:  Suhaer Zeki Al-Fadhel; Hussein Kadhem Al-Hakeim; Arafat Hussein Al-Dujaili; Michael Maes
Journal:  Eur Psychiatry       Date:  2019-01-21       Impact factor: 5.361

6.  Association between single nucleotide polymorphisms of MUTYH, hOGG1 and NEIL1 genes, and depression.

Authors:  Piotr Czarny; Dominik Kwiatkowski; Piotr Galecki; Monika Talarowska; Agata Orzechowska; Kinga Bobinska; Anna Bielecka-Kowalska; Janusz Szemraj; Michael Maes; Kuan-Pin Su; Tomasz Sliwinski
Journal:  J Affect Disord       Date:  2015-06-03       Impact factor: 4.839

7.  Primary hyperparathyroidism as a secondary cause of depression.

Authors:  Katherine Hurst
Journal:  J Am Board Fam Med       Date:  2010 Sep-Oct       Impact factor: 2.657

8.  Country- and individual-level socioeconomic determinants of depression: multilevel cross-national comparison.

Authors:  Dheeraj Rai; Pedro Zitko; Kelvyn Jones; John Lynch; Ricardo Araya
Journal:  Br J Psychiatry       Date:  2013-01-24       Impact factor: 9.319

9.  Effects of oral magnesium supplementation on inflammatory markers in middle-aged overweight women.

Authors:  Nazanin Moslehi; Mohammadreza Vafa; Abbas Rahimi-Foroushani; Banafsheh Golestan
Journal:  J Res Med Sci       Date:  2012-07       Impact factor: 1.852

10.  Interleukin-1β Processing Is Dependent on a Calcium-mediated Interaction with Calmodulin.

Authors:  Joseph S Ainscough; G Frank Gerberick; Ian Kimber; Rebecca J Dearman
Journal:  J Biol Chem       Date:  2015-11-11       Impact factor: 5.157

View more
  3 in total

Review 1.  Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia.

Authors:  Gerwyn Morris; Luba Sominsky; Kenneth R Walder; Michael Berk; Wolfgang Marx; André F Carvalho; Chiara C Bortolasci; Michael Maes; Basant K Puri
Journal:  Mol Neurobiol       Date:  2022-03-26       Impact factor: 5.682

2.  Correlation of Ionized Magnesium with the Parameters of Oxidative Stress as Potential Biomarkers in Patients with Anxiety and Depression: A Pilot Study.

Authors:  Ana Opanković; Srđan Milovanović; Branimir Radosavljević; Milena Čavić; Irina Besu Žižak; Zoran Bukumirić; Milan Latas; Branislava Medić; Sonja Vučković; Dragana Srebro; Katarina Savić Vujović
Journal:  Dose Response       Date:  2022-07-21       Impact factor: 2.623

3.  Intersections between Copper, β-Arrestin-1, Calcium, FBXW7, CD17, Insulin Resistance and Atherogenicity Mediate Depression and Anxiety Due to Type 2 Diabetes Mellitus: A Nomothetic Network Approach.

Authors:  Hussein Kadhem Al-Hakeim; Hadi Hasan Hadi; Ghoufran Akeel Jawad; Michael Maes
Journal:  J Pers Med       Date:  2022-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.